July 2024 – Page 50 – Goldea Capital

First Hawaiian, Inc. Reports Second Quarter 2024 Financial Results and Declares Dividend

Written by Customer Service on July 26, 2024. Posted in Earnings Releases And Operating Results.

HONOLULU, July 26, 2024 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ:FHB), (“First Hawaiian” or the “Company”) today reported financial results for its quarter ended June 30, 2024. “I’m pleased to report our strong financial results for the second quarter,” said Bob Harrison, Chairman, President, and CEO. “Our performance was driven by solid revenues, disciplined expense control and continued excellent credit quality. Additionally, we continued our support of the Maui community by partnering with the Federal Home Loan Bank of Des Moines to contribute a total of $1 million in relief funding for homeowners impacted by the Maui Wildfires.” On July 24, 2024, the Company’s Board of Directors declared a quarterly cash dividend of $0.26 per share. The dividend will be payable on August 30, 2024, to stockholders of record at the close...

Oxford Lane Capital Corp. Announces Net Asset Value and Selected Financial Results for the First Fiscal Quarter and Declaration of Distributions on Common Stock for the Months Ending October, November, and December 2024

Written by Customer Service on July 26, 2024. Posted in Earnings Releases And Operating Results.

GREENWICH, Conn., July 26, 2024 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (Nasdaq: OXLC) (NasdaqGS: OXLCP) (NasdaqGS: OXLCL) (NasdaqGS: OXLCO) (NasdaqGS: OXLCZ) (NasdaqGS: OXLCN) (NasdaqGM: OXLCI) (“Oxford Lane,” the “Company,” “we,” “us” or “our”) announced today the following financial results and related information: On July 25, 2024, our Board of Directors declared the following distributions on our common stock: Month Ending Record Date Payment Date Amount Per Share October 31, 2024 October 17, 2024 October 31, 2024 $0.09 November 30, 2024 November 15, 2024 November 29, 2024 $0.09 December 31, 2024 December 17, 2024 December 31, 2024 $0.09 Net asset value (“NAV”) per share as of June 30, 2024 stood at $4.91, compared with a NAV per share on March 31, 2024 of $4.90. Net investment income (“NII”),...

Howard Hughes Holdings Inc. Reports Second Quarter 2024 Results

Written by Customer Service on July 26, 2024. Posted in Earnings Releases And Operating Results.

Strong performance continues across core businesses with record-setting price per acre in MPCs and improved full-year guidance for Operating Assets and Condos THE WOODLANDS, Texas, July 26, 2024 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) (the “Company,” “HHH,” or “we”) today announced operating results for the second quarter ended June 30, 2024. The financial statements, exhibits, and reconciliations of non-GAAP measures in the attached Appendix and the Supplemental Information, as available through the Investors section of our website, provide further detail of these results. Second Quarter 2024 Highlights: Net income per diluted share of $0.42 compared to a loss of $(0.39) in the prior-year period MPC EBT of $123 million driven by an impressive 315% year-over-year increase in residential land sales at a record...

Balchem Corporation Reports Second Quarter 2024 Financial Results

Written by Customer Service on July 26, 2024. Posted in Earnings Releases And Operating Results.

MONTVALE, N.J., July 26, 2024 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal second quarter ended June 30, 2024. The Company reported quarterly net sales of $234.1 million, quarterly net earnings of $32.1 million, adjusted EBITDA(a) of $62.3 million, and free cash flow(a) of $38.4 million. Ted Harris, Chairman, President and CEO of Balchem said, “We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth.” Second Quarter 2024 Financial Highlights: Net sales were $234.1 million, an increase of 1.2% compared to the prior year quarter. Adjusted EBITDA...

United Community Banks, Inc. Announces Transfer of Listing of Common Stock and Depositary Shares to NYSE

Written by Customer Service on July 26, 2024. Posted in Public Companies.

GREENVILLE, S.C., July 26, 2024 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NASDAQ: UCBI; UCBIO) (the “Company” or “United”) announced today that the Company will transfer the listing of its common stock and its Depositary Shares (each representing 1/1000th interest in a share of Series I Non-Cumulative Preferred Stock) from the Nasdaq Stock Market LLC (“Nasdaq”) to the New York Stock Exchange (“NYSE”). The Company expects to commence trading as a NYSE-listed company upon market open on August 6, 2024. United’s common stock and depositary shares will trade under new ticker symbols, “UCB” and “UCB PRI”, respectively, after the transfer. The Company’s common stock and depositary shares will continue to trade on Nasdaq until the close of the market on August 5, 2024. “We are excited to announce our partnership with NYSE,” said United CEO, Lynn...

Dragonfly Energy to Report Second Quarter 2024 Financial and Operational Results on August 14, 2024

Written by Customer Service on July 26, 2024. Posted in Public Companies.

RENO, Nev., July 26, 2024 (GLOBE NEWSWIRE) — Dragonfly Energy Holdings Corp. (“Dragonfly Energy” or the “Company”) (Nasdaq: DFLI), maker of Battle Born Batteries® and an industry leader in energy storage, today announced that the Company will release its financial and operational results for the second quarter ended June 30, 2024 after market close on Wednesday, August 14, 2024. The earnings press release will be followed by a conference call on August 14, 2024 at 5:00 PM Eastern Time. Interested investors and other parties may access the live webcast via the link found here or through the Events and Presentations page within the Investor Relations section of Dragonfly Energy’s website at https://investors.dragonflyenergy.com/events-and-presentations/default.aspx. The call can also be accessed live via telephone by dialing (800)...

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Written by Customer Service on July 26, 2024. Posted in Public Companies.

TOKYO and CAMBRIDGE, Mass., July 26, 2024 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion on the Marketing Authorization Approval (MAA) for the humanized anti-soluble aggregated amyloid-beta (Aβ) monoclonal antibody lecanemab as treatment for early AD (mild cognitive impairment due to Alzheimer’s disease (AD) and mild AD).1 “We are extremely disappointed by the CHMP’s negative opinion and understand that this may also be disappointing for the wider Alzheimer’s disease (AD) community. AD is an irreversible, neurodegenerative disease...

Apollo Leads $700M Capital Solution for Sony Music Group

Written by Customer Service on July 26, 2024. Posted in Public Companies.

NEW YORK, July 26, 2024 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that, on behalf of its affiliated and third-party insurance clients and other investors, it has provided a $700 million capital solution to Sony Music Group, an affiliate of Sony Group Corporation (“Sony”), for investments in the music industry. “We are pleased to provide a bespoke capital solution to an affiliate of one of the world’s leading companies. This investment allows our clients to invest in high grade securities while helping Sony to execute its business plans,” said Apollo Partner Jamshid Ehsani. About Apollo Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade to private equity with a focus...

Vivid Seats to Report Second Quarter 2024 Financial Results

Written by Customer Service on July 26, 2024. Posted in Public Companies.

CHICAGO, July 26, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ:SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, will report financial results for the second quarter 2024 on Tuesday, August 6, 2024, before the U.S. stock market opens. Management will discuss the results on a webcast at 8:30 a.m. ET. The live webcast and replay can be accessed at https://investors.vividseats.com/. About Vivid Seats Founded in 2001, Vivid Seats is a leading online ticket marketplace committed to becoming the ultimate partner for connecting fans to the live events, artists, and teams they love. Based on the belief that everyone should “Experience It Live,” the Chicago-based company provides exceptional...

Chemomab Therapeutics Regains Compliance With Nasdaq Minimum Bid Price Requirement

Written by Customer Service on July 26, 2024. Posted in Public Companies.

TEL AVIV, Israel, July 26, 2024 (GLOBE NEWSWIRE) — Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab) a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, today announced that it has received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), informing the Company that it has regained compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2). Chemomab had previously announced on November 6, 2023, that it was notified by Nasdaq that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2), as the closing bid price of the Company’s American Depositary Shares (“ADSs”) had been below $1.00 for more than 30 consecutive...

Month: July 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice